UK researchers have made a positive step towards identifying blood biomarkers that could help predict response to anti-TNF treatment. Researcher and presenter James Oliver from Arthritis Research UK Centre said while biologic therapy had revolutionised the treatment of rheumatoid arthritis up to 40 percent of patients do not respond adequately to medication. “While we can’t ...
A step closer to biomarker guided treatment decisions
By Nicola Garrett
16 Jun 2016